CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: In addition, in contrast to primitive CML CD34+ cells, treatment of metformin did not induce apoptosis of human CML K562 cell lines but arrested cell cycle at the S phase after 48 h treatment (Supplemental Fig. 3) showing a discrepancy between CML cultured cell lines and primary cells.